{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:02:36Z","timestamp":1789214556910,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Brown tumor is usually caused by primary or secondary hyperparathyroidism but is exceptionally rare after kidney transplantation. Their rarity and atypical pathological features make diagnosis and treatment particularly challenging. We present a case of a 38-year-old woman with multiple brown tumors secondary to persistent hyperparathyroidism following kidney transplantation. The patient was initially admitted to the orthopedic department for left shoulder dislocation and lytic lesions in the left humerus and was diagnosed with a giant cell tumor of bone. Further investigations revealed elevated parathyroid hormone (PTH) levels and multiple lytic bone lesions throughout the skeleton. Based on these findings, the patient was ultimately diagnosed with multiple brown tumors. As a result, the patient underwent total parathyroidectomy and autotransplantation of parathyroid tissue. Follow-up evaluations showed decreased PTH levels and alkaline phosphatase levels, with improvement in skeletal changes. This case report shares the experience and lessons in managing hyperparathyroidism, both before and after kidney transplantation, emphasizing the importance of clinicians\u2019 awareness of the disease and multidisciplinary collaborative management.<\/jats:p>","DOI":"10.3389\/fendo.2025.1645715","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:12:27Z","timestamp":1757995947000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Management of multiple brown tumors after kidney transplantation"],"prefix":"10.3389","volume":"16","author":[{"given":"Qingyi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruman","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.11.14","article-title":"Multiple bone brown tumor secondary to primary hyperparathyroidism: a case report and literature review","volume":"8","author":"Xu","year":"2019","journal-title":"Gland Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-015-1344-5","article-title":"Surgical management of secondary hyperparathyroidism in chronic kidney disease\u2014a consensus report of the European Society of Endocrine Surgeons","volume":"400","author":"Lorenz","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000259621.56861.31","article-title":"Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients","volume":"83","author":"Rao","year":"2007","journal-title":"Transplantation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"B5","first-page":"69","article-title":"Graft and quality of life outcomes in older recipients of a kidney transplant","volume":"1","author":"Humar","year":"2003","journal-title":"Exp Clin Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00142.x","article-title":"Persistent secondary hyperparathyroidism after renal transplantation","volume":"54","author":"Messa","year":"1998","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.surg.2021.03.067","article-title":"Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients","volume":"171","author":"Sutton","year":"2022","journal-title":"Surgery"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1221060","article-title":"Specific genetic aberrations of parathyroid in Chinese patients with tertiary hyperparathyroidism using whole\u2013exome sequencing","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005522","article-title":"The American Association of Endocrine Surgeons Guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism","volume":"276","author":"Dream","year":"2022","journal-title":"Ann Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14664","article-title":"Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID\u201319","volume":"96","author":"Apayd\u0131n","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15026825","article-title":"Association of vitamin D receptor gene polymorphisms with end\u2013stage renal disease and the development of high\u2013turnover renal osteodystrophy in a Chinese population","volume":"15","author":"Wang","year":"2016","journal-title":"Genet Mol Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/2277-9175.143260","article-title":"The influence of BsmI and TaqI vitamin D receptor gene polymorphisms on the intensity of hyperparathyroidism in Iranian hemodialysis patients","volume":"3","author":"Pourfarzam","year":"2014","journal-title":"Adv BioMed Res"},{"key":"B15","first-page":"394","article-title":"Relationship between vitamin D receptor gene FokI and ApaI polymorphisms and serum levels of fetuin\u2013A, vitamin D, and parathyroid hormone in patients on hemodialysis","volume":"8","author":"Ghorbanihaghjo","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.10.1768","article-title":"The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation","volume":"17","author":"Giannini","year":"2002","journal-title":"J Bone Miner Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.jomfp_409_20","article-title":"Brown tumor of hyperparathyroidism with multiple lesions","volume":"26","author":"Majumdar","year":"2022","journal-title":"J Oral Maxillofac Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2023.108823","article-title":"Brown tumor of the jaw as a rare manifestation of hyperparathyroidism: Two case reports and literature review","volume":"111","author":"Hakkou","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001963","article-title":"Brown tumors belong to the spectrum of KRAS\u2013driven neoplasms","volume":"46","author":"Turek","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e10403.232","DOI":"10.1002\/jbm4.10403","article-title":"Osteitis fibrosa cystica","author":"Misiorowski","year":"2020","journal-title":"JBMR"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.2024S132","article-title":"Update on brown tumor of hyperparathyroidism","volume":"70","author":"Guedes","year":"2024","journal-title":"Rev Assoc Med Bras"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12882-024-03455-8","article-title":"The refractory secondary hyperparathyroidism presenting with retro\u2013orbital brown tumor: a case report","volume":"25","author":"Uysal","year":"2024","journal-title":"BMC Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-006-0068-4","article-title":"Brown tumor with fluid\u2013fluid levels in a patient with primary hyperparathyroidism: radiological findings","volume":"24","author":"Takeshita","year":"2006","journal-title":"Radiat Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-010-0979-0","article-title":"Emphasis on the MR imaging findings of brown tumor: a report of five cases","volume":"40","author":"Hong","year":"2011","journal-title":"Skeletal Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S1015-9584(24)02052-9","DOI":"10.1016\/j.asjsur.2024.08.253","article-title":"Differential diagnosis of Brown tumors and bone metastases in parathyroid carcinoma using 18F\u2013FDG PET\/CT and 99mTc\u2013MIBI SPECT\/CT: A case report","volume":"47","author":"Ma","year":"2024","journal-title":"Asian J Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199806000-00113","article-title":"Sphenoid sinus brown tumor of secondary hyperparathyroidism: case report","volume":"42","author":"Kanaan","year":"1998","journal-title":"Neurosurgery"},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2017.11.020","article-title":"Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant\u2013specific antibodies for giant cell tumors of bone","volume":"73","author":"Yamamoto","year":"2018","journal-title":"Hum Pathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.mayocp.2014.08.025","article-title":"Brown tumors: Severe osteitis fibrosa cystica","volume":"90","author":"Rodr\u00edguez\u2013Guti\u00e9rrez","year":"2015","journal-title":"Mayo Clinic Proc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1590\/s1516\u201331802009000200004","article-title":"Prevalence of radiological findings among cases of severe secondary hyperparathyroidism","volume":"127","author":"Lacativa","year":"2009","journal-title":"Sao Paulo Med J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001449","article-title":"Recent changes in chronic kidney disease\u2013mineral and bone disorders and associated fractures after kidney transplantation","volume":"101","author":"Perrin","year":"2017","journal-title":"Transplantation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4469","article-title":"Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: A prespecified secondary endpoint analysis of a randomized controlled trial","volume":"37","author":"Tsujita","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"CD005015","DOI":"10.1002\/14651858.CD005015.pub3","article-title":"Interventions for preventing bone disease in kidney transplant recipients","volume":"3","author":"Palmer","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice\u2013yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: A randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.019","article-title":"Interventions for preventing bone disease in kidney transplant recipients: Editorial summary of a Cochrane review","volume":"75","author":"Palmer","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10554","article-title":"Systematic review of surgical and medical treatment for tertiary hyperparathyroidism","volume":"104","author":"Dulfer","year":"2017","journal-title":"Br J Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-024-05372-9","article-title":"Brown tumors: Retrospective analysis of 26 cases","volume":"144","author":"Karaca","year":"2024","journal-title":"Arch Orthopaedic Trauma Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10554","article-title":"Brown tumor of the cervical spine with primary hyperparathyroidism: A case report and literature review","volume":"102","author":"Liu","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-019-00398-0","article-title":"Brown tumor of the thoracic spine presenting with paraplegia in a patient with peritoneal dialysis","volume":"8","author":"Eroglu","year":"2019","journal-title":"CEN Case Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","volume":"26","author":"Jain","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.07.005","article-title":"Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter","volume":"152","author":"Carsello","year":"2012","journal-title":"Surgery"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1677\/JME-10-0128","article-title":"Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor","volume":"46","author":"Ritter","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"B42","article-title":"BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients","volume":"16","author":"Borr\u00e0s","year":"2003","journal-title":"J Nephrol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1542","article-title":"Vitamin D receptor in osteoblasts is a negative regulator of bone mass control","volume":"154","author":"Yamamoto","year":"2013","journal-title":"Endocrinology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1911-156","article-title":"Vitamin D receptor polymorphisms and bone health after kidney transplantation","volume":"51","author":"Korucu","year":"2021","journal-title":"Turkish J Med Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1645715\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:12:31Z","timestamp":1757995951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1645715\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":44,"alternative-id":["10.3389\/fendo.2025.1645715"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1645715","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"article-number":"1645715"}}